Arthur Rosenthal

Arthur Rosenthal

Director/Board Member at PROFOUND MEDICAL CORP.

Net worth: 147 569 $ as of 2024-03-30

77 year
Health Technology
Consumer Services
Finance

Profile

Arthur L.
Rosenthal
founded Geyecue Medical Systems Ltd.
in 2011, where he is working as Chief Executive Officer from 2011 and EyeCue, Inc. in 2011, where he worked as Chief Executive Officer from 2011 to 2015.
Dr. Rosenthal also currently works at Arch Biosurgery, Inc., as Chairman from 2011, Interface Biologics, Inc., as Chairman from 2011, Profound Medical Corp., as Independent Director from 2018, and Boston University College of Engineering, as Professor from 2010.
Dr. Rosenthal also formerly worked at Cappella, Inc., as President & Chief Executive Officer from 2009 to 2011, Labcoat Ltd., as Chairman & Chief Executive Officer from 2005 to 2008, ArraVasc Ltd., as Executive Vice Chairman from 2011 to 2012, LivaNova USA, Inc., as Independent Non-Executive Director in 2015, HydroCision, Inc., as Director, Ultimate Finance Holdings Ltd., as Non-Executive Director from 2000 to 2010, Tornado Medical Systems, Inc., as Director from 2011 to 2012, Renovo Ltd., as Non-Executive Director from 2000 to 2010, Arch Therapeutics, Inc., as Director, Arch Therapeutics, Inc., as Independent Director from 2011 to 2015, LivaNova Plc, as Independent Director from 2015 to 2022, Arch Technologies, Inc., as Non-Executive Director from 2013 to 2015, Advent International LP, as Venture Advisor from 2005 to 2007, C.
R.
Bard, Inc. (New Jersey), as Vice President-Research & Development, Boston Scientific Corp., as Chief Scientific Officer & Senior Vice President from 1994 to 2005, Davol, Inc., as Vice President from 1982 to 1991, Pfizer Ltd., as Chief Scientific Officer, and Johnson & Johnson Medical, Inc., as Vice President-Research & Development.
Dr. Rosenthal received his undergraduate degree from the University of Connecticut and doctorate degree in 1973 from the University of Massachusetts.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-05 17,300 ( 0.07% ) 147 569 $ 2024-03-30

Arthur Rosenthal active positions

CompaniesPositionStart
PROFOUND MEDICAL CORP. Director/Board Member 2018-06-13
Boston University College of Engineering Corporate Officer/Principal 2010-05-31
Arch Biosurgery, Inc. Chairman 2011-03-31
Geyecue Medical Systems Ltd. Chief Executive Officer 2011-11-30
Chairman 2011-03-31
All active positions of Arthur Rosenthal

Former positions of Arthur Rosenthal

CompaniesPositionEnd
LIVANOVA PLC Director/Board Member 2022-06-12
CYBERONICS, INC. Director/Board Member 2015-10-17
ARCH THERAPEUTICS, INC. Director/Board Member 2015-05-27
Arch Technologies, Inc. Director/Board Member 2015-04-30
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Arthur Rosenthal's experience

Training of Arthur Rosenthal

University of Connecticut Undergraduate Degree
University of Massachusetts Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Arthur Rosenthal's experience

Connections

99

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
BOSTON SCIENTIFIC CORPORATION

Distribution Services

ARCH THERAPEUTICS, INC.

Distribution Services

LIVANOVA PLC

Health Technology

PROFOUND MEDICAL CORP.

Health Technology

Private companies19

Finance

Health Technology

Health Technology

Health Technology

Finance

Arch Biosurgery, Inc.

Health Technology

Tornado Medical Systems, Inc.

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Arch Therapeutics, Inc. /Old/

Health Technology

Geyecue Medical Systems Ltd.

Arch Technologies, Inc.

EyeCue, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Arthur Rosenthal